Theratechnologies company info

What does Theratechnologies do?
Theratechnologies (TSX:TH), (NASDAQ:THTX), a biopharmaceutical company, focuses on innovative therapies for metabolic disorders and conditions, notably in areas related to HIV. It actively engages in the research, development, and commercialization of products aimed at improving the quality of life for people dealing with metabolic diseases. Among its notable projects are treatments for complications associated with HIV, including excess abdominal fat in HIV-infected patients on antiretroviral therapy. A key objective for Theratechnologies is to advance their pipeline of products through clinical trials, ensuring they meet rigorous safety and efficacy standards. Their pursuit of medical breakthroughs is aimed at addressing unmet medical needs, making a significant impact on patient care in their target markets.
Theratechnologies company media
Company Snapshot

Is Theratechnologies a public or private company?

key
Ownership
Public

How many people does Theratechnologies employ?

people
Employees
103

What sector is Theratechnologies in?

pie chart
Sector
Health Care

Where is the head office for Theratechnologies?

location pin
Head Office
Montreal, Canada

What year was Theratechnologies founded?

founded flag
Year Founded
1993
What does Theratechnologies specialise in?
/Pharmaceutical Development /HIV Treatments /Oncology Therapies /NASH Treatment /Commercialization Services /Biomedical Research

What are the products and/or services of Theratechnologies?

Overview of Theratechnologies offerings
EGRIFTA and EGRIFTA SV, treatments aimed at reducing excess abdominal fat in HIV-infected patients with lipodystrophy.
TESAMORELIN, a growth hormone-releasing factor analog for the treatment of lipodystrophy.
F8 Formulation technology, designed to improve the delivery and effectiveness of existing medications.
TROGARZO, an antiretroviral therapy for multidrug-resistant HIV-1 infection.
TH1902, a targeted therapy for sortilin-positive cancers in the preclinical development stage.
Research and development efforts focused on metabolic disorders and HIV, exploring innovative solutions to address unmet medical needs.

Who is in the executive team of Theratechnologies?

Theratechnologies leadership team
  • Mr. Paul  Lévesque
    Mr. Paul Lévesque
    President, CEO & Director
  • Mr. Philippe  Dubuc M.B.A., MBA
    Mr. Philippe Dubuc M.B.A., MBA
    Senior VP & CFO
  • Mr. Jocelyn  Lafond L.L.M., LL.B.
    Mr. Jocelyn Lafond L.L.M., LL.B.
    General Counsel & Corporate Secretary
  • Dr. Christian  Marsolais Ph.D.
    Dr. Christian Marsolais Ph.D.
    Senior VP & Chief Medical Officer
  • Mr. John  Leasure
    Mr. John Leasure
    Global Commercial Officer
  • Hon. Andre  Dupras M.Sc.
    Hon. Andre Dupras M.Sc.
    Vice President of Human Resources